2016 Section 5 Green Book

32. Ganong WF. The adrenalmedulla and adrenal cortex. In Review of Medical Physiology, 22nd ed. Ganong WF (Ed). New York: McGraw- Hill, 356–381, 2007. 33. Downie WW, Dixon JS, Lowe JR, et al. Adrenocortical suppression by synthetic corticosteroid drugs: A comparative study of prednisolone and betamethasone. Br J Clin Pharmacol 6:397–399, 1978. 34. Wilson AM, McFarlane LC, and Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest 114:1022–1027, 1998. 35. LaRochelle GE Jr, LaRochelle AG, Ratner RE, and Borenstein DG. Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in pa- tients with rheumatic diseases receiving low-dose prednisone. Am J Med 95:258–264, 1993. 36. Warrington TP, and Bostwick JM. Psychiatric adverse effects of cor- ticosteroids. Mayo Clin Proc 81:1361–1367, 2006. 37. Lewis DA, and Smith RE. Steroid-induced psychiatric syndromes. J Affect Disord 5:319–332, 1983. 38. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694–698, 1972. 39. Kershner P, and Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 30:135–139, 1989. 40. Fink JL III. Liability claims based on drug use. Drug Intell Clin Pharm 17:667–670, 1983. 41. Crane M. The medication errors that get doctors sued. Med Econ 70:36–38, 40–41, 1993. 42. Rothschild JM, Federico FA, Gandhi TK, et al. Analysis of medication- related malpractice claims. Arch Intern Med 162:2414–2420, 2002. 43. Nash JJ, Nash AG, Leach ME, and Poetker DM. Medical malpractice and corticosteroid use. Otolaryngol Head Neck Surg 144:10–15, 2011. 44. Poetker DM, and Smith TL. What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: A review of the literature. Int Forum Allergy Rhinol 2:95–103, 2012. 45. Poetker DM, Jakubowski LA, Lal D, et al. Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: An evidence-based review with recommendations. Int Forum Allergy Rhinol 3:104–120, 2013. 46. Lal D, Scianna JM, and Stankiewicz JA. Efficacy of targeted medical therapy in chronic rhinosinusitis, and predictors of failure. Am J Rhinol Allergy 23:396–400, 2009. 47. Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol 16:303–312, 2002. 48. Hessler JL, Piccirillo JF, Fang D, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: Results of a prospec- tive study. Am J Rhinol 21:10–18, 2007. 49. Ikeda K, Sakurada T, Suzaki Y, and Takasaka T. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease. Rhinology 33:162–165, 1995. 50. Jankowski R, and Bodino C. Olfaction in patients with nasal polyp- osis: Effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization). Rhinology 41:220–230, 2003. 51. Jankowski R, and Bodino C. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid–radical ethmoidectomy is functional surgery for NPS. Rhinology 41:211–219, 2003. 52. Vaidyanathan S, Williamson P, Anderson K, and Lipworth B. Effect of systemic steroids on humming nasal nitric oxide in chronic rhino- sinusitis with nasal polyposis. Ann Allergy Asthma Immunol 105: 412–417, 2010. 53. Landsberg R, Segev Y, DeRowe A, et al. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal

polyposis: A comparative study. Otolaryngol Head Neck Surg 136: 252–257, 2007. 54. Damm M, Jungehulsing M, Eckel HE, et al. Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 120:517–523, 1999. 55. van Camp C, and Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 32:5–9, 1994. 56. Tuncer U, Soylu L, Aydogan B, et al. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx 30:263–268, 2003. 57. Rasp G, Kramer MF, Ostertag P, and Kastenbauer E. A new system for the classification of ethmoid polyposis. Effect of combined local and systemic steroid therapy. Laryngorhinootologie 79:266–272, 2000. 58. Blomqvist EH, Lundblad L, Anggard A, et al. A randomized con- trolled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 107:224–228, 2001. 59. Benitez P, Alobid I, de Haro J, et al. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 116:770–775, 2006. 60. Alobid I, Benitez P, Pujols L, et al. Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. Rhinology 44:8– 13, 2006. 61. Kroflic B, Coer A, Baudoin T, and Kalogjera L. Topical furosemide versus oral steroid in preoperative management of nasal polyposis. Eur Arch Otorhinolaryngol 263:767–771, 2006. 62. Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxy- cycline: Two different approaches to treat nasal polyps. J Allergy Clin Immunol 125:1069–1076, 2010. 63. Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic corticosteroids in sinonasal polyposis: A double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J Al- lergy Clin Immunol 118:128–133, 2006. 64. Vaidyanathan S, Barnes M, Williamson P, et al. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: A randomized trial. Ann Intern Med 154:293–302, 2011. 65. Kirtsreesakul V, Wongsritrang K, Ruttanaphol S. Clinical efficacy of a short course of systemic steroids in nasal polyposis. Rhinology 49:525–532, 2011. 66. Sieskiewicz A, Olszewska E, Rogowski M, and Grycz E. Preoperative corticosteroid oral therapy and intraoperative bleeding during func- tional endoscopic sinus surgery in patients with severe nasal polyp- osis: A preliminary investigation. Ann Otol Rhinol Laryngol 115:490– 494, 2006. 67. Wright ED, and Agrawal S. Impact of perioperative systemic steroids on surgical outcomes in patients with chronic rhinosinusitis with polyposis: Evaluation with the novel perioperative sinus endoscopy (POSE) scoring system. Laryngoscope 117(Suppl 115):1–28, 2007. 68. Giordano J, Darras J, Chevalier D, and Mortuaire G. Preoperative corticosteroid treatment and nasal polyposis. Ann Otolaryngol Chir Cervicofac 126:120–124, 2009. 69. Ocampo CJ, and Peters AT. Medical therapy as the primary modality for the management of chronic rhinosinusitis. Allergy Asthma Proc 34:132–137, 2013. 70. Ramakrishnan VR, Kingdom TT, Nayak JV, et al. Nationwide inci- dence of major complications in endoscopic sinus surgery. Int Forum Allergy Rhinol 2:34–39, 2012. 71. Poetker DM, and Smith TL. What rhinologists and allergists should know about the medico-legal implications of antibiotic use: A review of the literature. Int Forum Allergy Rhinol 5:104–110, 2015. e

September–October 2015, Vol. 29, No. 5

142